loading
前日終値:
$2.06
開ける:
$2.04
24時間の取引高:
18,033
Relative Volume:
1.00
時価総額:
$20.96M
収益:
-
当期純損益:
$-17.93M
株価収益率:
-0.9345
EPS:
-2.29
ネットキャッシュフロー:
$-14.28M
1週間 パフォーマンス:
-2.50%
1か月 パフォーマンス:
+2.14%
6か月 パフォーマンス:
+12.89%
1年 パフォーマンス:
+31.60%
1日の値動き範囲:
Value
$2.0011
$2.20
1週間の範囲:
Value
$1.99
$2.45
52週間の値動き範囲:
Value
$1.325
$3.10

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name
名前
Cocrystal Pharma Inc
Name
セクター
Healthcare (1195)
Name
電話
(786) 459-1831
Name
住所
19805 N. CREEK PARKWAY, BOTHELL, WA
Name
職員
12
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
COCP's Discussions on Twitter

COCP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
COCP 2.14 20.96M 0 -17.93M -14.28M -2.29
VRTX 449.15 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.55 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 598.26 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.12 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.14 24.89B 3.30B -501.07M 1.03B 11.54

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-07-08 開始されました H.C. Wainwright Buy

Cocrystal Pharma Inc (COCP) 最新ニュース

pulisher
Nov 20, 2024

Cocrystal Pharma (STU:8CC) 14-Day RSI : 67.70 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Cocrystal Pharma (STU:8CC) GF Value Rank : 10 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 14, 2024

November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Cocrystal Pharma (STU:8CC) 3-Year EPS without NRI Growth Ra - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Cocrystal Pharma Advances Clinical Trials Despite $4.9M Q3 Loss, Key Results Expected | COCP Stock News - StockTitan

Nov 13, 2024
pulisher
Oct 31, 2024

Cocrystal Pharma Advances Antiviral Drug Development - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Cocrystal Pharma's Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - The Manila Times

Oct 31, 2024
pulisher
Oct 18, 2024

Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation - Yahoo Finance

Oct 18, 2024
pulisher
Oct 15, 2024

Pharmaceutical Grade Hydroxytyrosol Market Poised for Growth - openPR

Oct 15, 2024
pulisher
Oct 14, 2024

Influenza Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - openPR

Oct 14, 2024
pulisher
Oct 14, 2024

Seasonal Influenza Treatment Market Size, Treatment Drugs, and Companies 2024 - openPR

Oct 14, 2024
pulisher
Oct 11, 2024

Cocrystal Pharma execs get pay raise and stock grants By Investing.com - Investing.com Canada

Oct 11, 2024
pulisher
Oct 10, 2024

Cocrystal Pharma execs get pay raise and stock grants - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Cocrystal Pharma Boosts Executive and Director Compensation - TipRanks

Oct 10, 2024
pulisher
Sep 27, 2024

Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma commences next phase of antiviral study - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma commences next phase of antiviral study By Investing.com - Investing.com Canada

Sep 26, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts - The Manila Times

Sep 26, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose - EIN News

Sep 26, 2024
pulisher
Sep 26, 2024

Seasonal Influenza Treatment Market Size in the 7MM was ~USD 9177 million in 2023, estimated DelveInsight - openPR

Sep 26, 2024
pulisher
Sep 25, 2024

Corover Secures $4 Mn In Series A Funding Led By Venture Catalysts - BW Disrupt

Sep 25, 2024
pulisher
Sep 24, 2024

K2 Principal Fund L.P. Takes $1.17 Million Position in CSLM Acquisition Corp. (NASDAQ:CSLM) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Coherent Corp (COHR) rating reiterates by Needham - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Corcel shares drop as explorer raise funds and ups exposure in Angola - Proactive Investors USA

Sep 24, 2024
pulisher
Sep 24, 2024

Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Corcel PLC Bolsters Angola Position with Increased Stake and Funding - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

Corcel (LON:CRCL) Trading 2.6% Higher - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Bearish block trade of CSPC PHARMA(01093) 768K shares at $4.94, $3.794M turnover - AASTOCKS.com

Sep 23, 2024
pulisher
Sep 21, 2024

CorVel Co. (NASDAQ:CRVL) Shares Acquired by Kayne Anderson Rudnick Investment Management LLC - MarketBeat

Sep 21, 2024
pulisher
Sep 20, 2024

Coherent (COHR) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance

Sep 20, 2024
pulisher
Sep 20, 2024

Momentum Is Driving Corning Stock Higher (NYSE:GLW) - Seeking Alpha

Sep 20, 2024
pulisher
Sep 20, 2024

Corbus stock reiterates Outperform rating despite trial data - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard

Sep 20, 2024
pulisher
Sep 19, 2024

Coherent Corp (COHR)’s Market Momentum: Closing Strong at 80.98, Up 3.93 - The Dwinnex

Sep 19, 2024
pulisher
Sep 19, 2024

Corning’s stock rises as it sticks to Q3 profit view - MarketWatch

Sep 19, 2024
pulisher
Sep 18, 2024

COHR’s Wild Ride: Up 82.75% – What’s Next for COHR? - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors - Morningstar

Sep 18, 2024
pulisher
Sep 18, 2024

Commonwealth Equity Services LLC Has $996,000 Holdings in Compass Diversified (NYSE:CODI) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Examining the Potential Price Growth of CoreCivic Inc (CXW) - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Coherent (NYSE:COHR) delivers shareholders stellar 135% return over 1 year, surging 6.3% in the last week alone - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Prepare Yourself for Liftoff: Coherent Corp (COHR) - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

Coherent Corp (COHR) receives a Buy rating from Needham - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Hollyland Cosmo C2 Wireless Video System First Look - Newsshooter

Sep 16, 2024
pulisher
Sep 16, 2024

State of New Jersey Common Pension Fund D Lowers Stock Holdings in Sea Limited (NYSE:SE) - Defense World

Sep 16, 2024
pulisher
Sep 16, 2024

LPL Financial LLC Has $46.81 Million Stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN) - Defense World

Sep 16, 2024
pulisher
Sep 13, 2024

CoreCivic Inc [CXW] stock for 106,240 USD was sold by Carter, Cole G. - Knox Daily

Sep 13, 2024

Cocrystal Pharma Inc (COCP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):